Inspire Investing LLC Raises Stock Holdings in Owens & Minor, Inc. (NYSE:OMI)

Inspire Investing LLC boosted its holdings in shares of Owens & Minor, Inc. (NYSE:OMI) by 15.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 33,526 shares of the company’s stock after purchasing an additional 4,421 shares during the quarter. Inspire Investing LLC’s holdings in Owens & Minor were worth $438,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of OMI. Quarry LP boosted its position in Owens & Minor by 290.1% during the second quarter. Quarry LP now owns 2,099 shares of the company’s stock worth $28,000 after purchasing an additional 1,561 shares in the last quarter. Blue Trust Inc. lifted its position in shares of Owens & Minor by 176.8% in the third quarter. Blue Trust Inc. now owns 2,787 shares of the company’s stock valued at $44,000 after acquiring an additional 1,780 shares in the last quarter. Canada Pension Plan Investment Board purchased a new position in shares of Owens & Minor in the second quarter valued at approximately $82,000. Meeder Asset Management Inc. lifted its position in shares of Owens & Minor by 844.1% in the third quarter. Meeder Asset Management Inc. now owns 9,016 shares of the company’s stock valued at $141,000 after acquiring an additional 8,061 shares in the last quarter. Finally, Marshall Wace LLP lifted its position in shares of Owens & Minor by 38.4% in the second quarter. Marshall Wace LLP now owns 11,100 shares of the company’s stock valued at $150,000 after acquiring an additional 3,077 shares in the last quarter. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Jonathan A. Leon sold 5,282 shares of Owens & Minor stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the sale, the chief financial officer now directly owns 130,822 shares of the company’s stock, valued at approximately $1,546,316.04. The trade was a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 3.59% of the stock is owned by insiders.

Owens & Minor Price Performance

OMI stock opened at $14.97 on Friday. The business has a fifty day moving average of $13.61 and a two-hundred day moving average of $14.28. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The stock has a market cap of $1.15 billion, a price-to-earnings ratio of -23.03, a price-to-earnings-growth ratio of 0.42 and a beta of 0.46. Owens & Minor, Inc. has a 52-week low of $11.42 and a 52-week high of $28.35.

Owens & Minor (NYSE:OMI) last posted its earnings results on Monday, November 4th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.41 by $0.01. The company had revenue of $2.72 billion during the quarter, compared to analysts’ expectations of $2.68 billion. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.44 earnings per share. As a group, research analysts anticipate that Owens & Minor, Inc. will post 1.49 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on OMI. Barclays decreased their target price on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. UBS Group decreased their target price on Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Robert W. Baird decreased their target price on Owens & Minor from $19.00 to $14.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 5th. Finally, Citigroup reduced their price objective on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $18.50.

Owens & Minor Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.